LeadIQ logo
Learn more at LeadIQ.com

Insights

Investment Opportunities Recent investments from Lazard Asset Management and Allspring Global Investments signal financial backing and potential interest in Alector's advancements, presenting avenues for partnership discussions or further funding opportunities.

Strategic Partnerships Collaborations with major companies like GlaxoSmithKline and Chapstick highlight Alector's ability to form strategic alliances, indicating a willingness to partner with industry leaders to drive innovation and market expansion.

Innovative Product Development Development of progranulin-elevating monoclonal antibodies and human monoclonal antibodies showcases Alector's cutting-edge research in neurological diseases, offering potential for product adoption by healthcare institutions and pharmaceutical distributors.

Industry Recognition Alector's focus on immuno-neurology and strategic collaborations have garnered attention in the biotechnology sector, positioning the company as a key player in the fight against neurodegenerative diseases, attracting interest from industry stakeholders and healthcare professionals.

Financial Stability With reported revenue in the range of $10M - $50M and recent financing of $75M strengthening their financial position, Alector demonstrates financial stability, indicating reliability for potential clients and investors seeking long-term partnerships.

Similar companies to Alector

Alector Tech Stack

Alector uses 8 technology products and services including Google Analytics, MariaDB, Flickity, and more. Explore Alector's tech stack below.

  • Google Analytics
    Analytics
  • MariaDB
    Database
  • Flickity
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • UNIX
    Operating Systems
  • HSTS
    Security
  • Animate.css
    UI Frameworks

Media & News

Alector's Email Address Formats

Alector uses at least 1 format(s):
Alector Email FormatsExamplePercentage
First.Last@alector.comJohn.Doe@alector.com
94%
FL@alector.comJD@alector.com
4%
FLast@alector.comJDoe@alector.com
1%
Last.First@alector.comDoe.John@alector.com
1%

Frequently Asked Questions

Where is Alector's headquarters located?

Minus sign iconPlus sign icon
Alector's main headquarters is located at 131 Oyster Point Blvd Suite 600 South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Alector's phone number?

Minus sign iconPlus sign icon
You can contact Alector's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alector's stock symbol?

Minus sign iconPlus sign icon
Alector is a publicly traded company; the company's stock symbol is ALEC.

What is Alector's official website and social media links?

Minus sign iconPlus sign icon
Alector's official website is alector.com and has social profiles on LinkedIn.

How much revenue does Alector generate?

Minus sign iconPlus sign icon
As of September 2024, Alector's annual revenue reached $35M.

What is Alector's SIC code NAICS code?

Minus sign iconPlus sign icon
Alector's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alector have currently?

Minus sign iconPlus sign icon
As of September 2024, Alector has approximately 268 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer Co-Founder Director: A. R.Chief Business Officer: N. B.Chief Medical Officer: G. R.. Explore Alector's employee directory with LeadIQ.

What industry does Alector belong to?

Minus sign iconPlus sign icon
Alector operates in the Biotechnology Research industry.

What technology does Alector use?

Minus sign iconPlus sign icon
Alector's tech stack includes Google AnalyticsMariaDBFlickityUnderscore.jsOpen GraphUNIXHSTSAnimate.css.

What is Alector's email format?

Minus sign iconPlus sign icon
Alector's email format typically follows the pattern of . Find more Alector email formats with LeadIQ.

How much funding has Alector raised to date?

Minus sign iconPlus sign icon
As of September 2024, Alector has raised $75M in funding. The last funding round occurred on Jan 17, 2024 for $75M.

When was Alector founded?

Minus sign iconPlus sign icon
Alector was founded in 2013.
Alector

Alector

Biotechnology ResearchCalifornia, United States201-500 Employees

We have always walked our own path at Alector. That’s what led us to our bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. 

Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. 

Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.

Section iconCompany Overview

Headquarters
131 Oyster Point Blvd Suite 600 South San Francisco, California 94080 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALEC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $75M

    Alector has raised a total of $75M of funding over 6 rounds. Their latest funding round was raised on Jan 17, 2024 in the amount of $75M.

  • $10M$50M

    Alector's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Alector has raised a total of $75M of funding over 6 rounds. Their latest funding round was raised on Jan 17, 2024 in the amount of $75M.

  • $10M$50M

    Alector's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.